Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 1
2011 1
2012 1
2013 3
2014 2
2015 2
2017 2
2018 3
2019 7
2020 2
2021 1
2022 3
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
The pathologic diagnosis of mantle cell lymphoma.
Li S, Xu J, You MJ. Li S, et al. Histol Histopathol. 2021 Oct;36(10):1037-1051. doi: 10.14670/HH-18-351. Epub 2021 Jun 11. Histol Histopathol. 2021. PMID: 34114641 Review.
Mantle cell lymphoma (MCL) is a mature B-cell non-Hodgkin lymphoma usually characterized by t(11;14) (q13;q32), or CCND1 translocation and Cyclin D1 over expression. ...
Mantle cell lymphoma (MCL) is a mature B-cell non-Hodgkin lymphoma usually characterized by t(11;1 …
Effect of rituximab on immune status in children with mature B-cell non-Hodgkin lymphoma: a prespecified secondary analysis of the Inter-B-NHL Ritux 2010 trial.
Alexander S, Aupérin A, Bomken S, Csóka M, Kazanowska B, Chiang AK, Andres M, Uyttebroeck A, Burke GAA, Zsiros J, Pillon M, Bollard CM, Mussolin L, Verdu-Amoros J, Neven B, Barkauskas DA, Wheatley K, Patte C, Gross TG, Minard-Colin V; Children's Oncology Group; European Intergroup for Childhood Non-Hodgkin's Lymphoma. Alexander S, et al. Lancet Haematol. 2023 Jun;10(6):e445-e457. doi: 10.1016/S2352-3026(23)00062-5. Epub 2023 Apr 21. Lancet Haematol. 2023. PMID: 37094596 Clinical Trial.
BACKGROUND: Survival of children and adolescents with high-risk, mature B-cell non-Hodgkin lymphoma is improved by the addition of rituximab to chemotherapy. ...METHODS: The Inter-B-NHL Ritux 2010 trial was an international, open-label, r …
BACKGROUND: Survival of children and adolescents with high-risk, mature B-cell non-Hodgkin lymphoma …
Cytogenetics in the management of mature B-cell non-Hodgkin lymphomas: Guidelines from the Groupe Francophone de Cytogénétique Hematologique (GFCH).
Lefebvre C, Veronese L, Nadal N, Gaillard JB, Penther D, Daudignon A, Chauzeix J, Nguyen-Khac F, Chapiro E. Lefebvre C, et al. Curr Res Transl Med. 2023 Oct-Dec;71(4):103425. doi: 10.1016/j.retram.2023.103425. Epub 2023 Oct 23. Curr Res Transl Med. 2023. PMID: 38016420 Review.
Non-Hodgkin lymphomas (NHL) consist of a wide range of clinically, phenotypically and genetically distinct neoplasms. The accurate diagnosis of mature B-cell non-Hodgkin lymphoma relies on a multidisciplinary approach that integrates morp …
Non-Hodgkin lymphomas (NHL) consist of a wide range of clinically, phenotypically and genetically distinct neoplasms. The accurate diagnosis …
Mature B-cell lymphoma and leukemia in children and adolescents-review of standard chemotherapy regimen and perspectives.
Worch J, Rohde M, Burkhardt B. Worch J, et al. Pediatr Hematol Oncol. 2013 Sep;30(6):465-83. doi: 10.3109/08880018.2013.783891. Epub 2013 Apr 9. Pediatr Hematol Oncol. 2013. PMID: 23570584 Review.
Mature B-cell non-Hodgkin lymphoma (B-NHL) comprises more than 50% of all non-Hodgkin lymphoma (NHL) in children and adolescents. ...
Mature B-cell non-Hodgkin lymphoma (B-NHL) comprises more than 50% of all non-Hodgkin lymphoma (NH …
Mature B-cell lymphoma in children and adolescents: International group pathologist consensus correlates with histology technical quality.
Lones MA, Raphael M, Perkins SL, Wotherspoon A, Auperin A, Terrier-Lacombe MJ, Sposto R, Weston C, Gerrard M, Patte C, Cairo MS, McCarthy K. Lones MA, et al. J Pediatr Hematol Oncol. 2006 Sep;28(9):568-74. doi: 10.1097/01.mph.0000212980.67114.a5. J Pediatr Hematol Oncol. 2006. PMID: 17006262
In pediatric mature B-cell non-Hodgkin lymphoma, international pathologist diagnostic agreement was previously evaluated using the Revised European-American Lymphoma Classification. ...The rate of uniform agreement between the national di …
In pediatric mature B-cell non-Hodgkin lymphoma, international pathologist diagnostic agreement wa …
No increased risk of mature B-cell non-Hodgkin lymphoma after Q fever detected: results from a 16-year ecological analysis of the Dutch population incorporating the 2007-2010 Q fever outbreak.
Weehuizen JM, van Roeden SE, Hogewoning SJ, van der Hoek W, Bonten MJM, Hoepelman AIM, Bleeker-Rovers CP, Wever PC, Oosterheert JJ. Weehuizen JM, et al. Int J Epidemiol. 2022 Oct 13;51(5):1481-1488. doi: 10.1093/ije/dyac053. Int J Epidemiol. 2022. PMID: 35352121 Free PMC article.
Pediatric mature B-cell NHL, early referral and supportive care problems in a developing country.
Gaytan-Morales F, Alejo-Gonzalez F, Reyes-Lopez A, Palomo M, Rodriguez-Romo L, Villareal-Martínez L, Sandoval-González A, Lopez-Facundo A, Tejocote-Romero I, Cárdenas-Cardos R, Aguilar-Ortiz M, Arreguin-Gonzalez F, Baños-Rodriguez E, Cortes-Alva D, Ellis-Irigoyen A, García-Becerra G, Rodriguez-Campos M, Gonzalez-Montalvo P, Gonzalez-Ramella O, Olaya-Vargas A; Mexican Association of Pediatric Oncology and Hematology (AMOHP). Gaytan-Morales F, et al. Hematology. 2019 Dec;24(1):79-83. doi: 10.1080/10245332.2018.1510087. Epub 2018 Aug 27. Hematology. 2019. PMID: 30149780
OBJECTIVE: Mature B-cell non-Hodgkin lymphoma (B-NHL) comprises more than 50% of all non-Hodgkin lymphoma (NHL) in children and adolescents. ...
OBJECTIVE: Mature B-cell non-Hodgkin lymphoma (B-NHL) comprises more than 50% of all non-Hodgkin l …
Prognostic Factors and Treatment Outcome of Relapsing and Refractory Pediatric Mature B-cell Non-Hodgkin Lymphoma, Children's Cancer Hospital Egypt Experience.
Semary SF, Abdel Rahman H, Elkinaai N, Zaky I, Nagy N, Salem S, Hamoda A. Semary SF, et al. J Pediatr Hematol Oncol. 2023 Aug 1;45(6):e757-e763. doi: 10.1097/MPH.0000000000002699. Epub 2023 Jun 26. J Pediatr Hematol Oncol. 2023. PMID: 37494612
PATIENTS: It is a retrospective study, including pediatric patients diagnosed as mature B-cell non-Hodgkin lymphoma who were primarily refractory or relapsed over 8 years at CCHE. ...
PATIENTS: It is a retrospective study, including pediatric patients diagnosed as mature B-cell non-Hodgkin …
Creation of a pediatric mature B-cell non-Hodgkin lymphoma cohort within the Pediatric Health Information System Database.
Citrin R, Horowitz JP, Reilly AF, Li Y, Huang YS, Getz KD, Seif AE, Fisher BT, Aplenc R. Citrin R, et al. PLoS One. 2017 Oct 23;12(10):e0186960. doi: 10.1371/journal.pone.0186960. eCollection 2017. PLoS One. 2017. PMID: 29059235 Free PMC article.
Mature B-cell non-Hodgkin lymphoma (B-NHL) constitutes a collection of relatively rare pediatric malignancies. ...
Mature B-cell non-Hodgkin lymphoma (B-NHL) constitutes a collection of relatively rare pediatric m …
A prospective multicenter study investigating rituximab combined with intensive chemotherapy in newly diagnosed pediatric patients with aggressive mature B cell non-Hodgkin lymphoma (CCCG-BNHL-2015): a report from the Chinese Children's Cancer Group.
Gao YJ, Fang YJ, Gao J, Yan J, Yang LC, Liu AG, Ju XL, Lu J, Han YL, Wang J, Xie M, Guo X, Tang JY. Gao YJ, et al. Ann Hematol. 2022 Sep;101(9):2035-2043. doi: 10.1007/s00277-022-04904-w. Epub 2022 Jul 13. Ann Hematol. 2022. PMID: 35829780
The evidence for the safety and efficacy of adding rituximab to intensive chemotherapy in pediatric patients with aggressive mature B cell non-Hodgkin lymphoma/leukemia (B-NHL/B-AL) is not yet robust. ...
The evidence for the safety and efficacy of adding rituximab to intensive chemotherapy in pediatric patients with aggressive mature …
31 results